COVID-19 has left everyone with more questions than answers. As we look past COVID-19 and into the future of the clinical trials industry, what does that future look like and how do we get there?
Join Mike Novotny, Founder of Medrio as he shares a trending analysis of our Clinical Trials Impact Survey, correlating Medrio data, and his predictions for the future of the industry.
Founder & Board Member of Medrio
Mike Novotny is the founder of Medrio and was CEO for 15 years. Mr. Novotny applies 25 years of research and software experience to his vision for cloud computing in life sciences. Before founding Medrio, Mr. Novotny was CEO of Telosa, President of Ninaza, a research associate at the UN, and the VISA fraud database manager. He holds a BA from Stanford University, an MA from PUC University in Chile, and an MBA from Columbia University.